COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,577 Articles (22,415 medRxiv, 8,162 bioRxiv)

Most recent first Previous |  Page 1264: Articles 12631-12640  | Next

COVID-19 Vaccine Uptake among U.S. Child Care Providers
Patel, K., Malik, A. A., Lee, A., Klotz, M., Humphries, J. E., Murray, T., Wilkinson, D., Shafiq, M., Yildirim, I., Elharake, J., Diaz, R., Reyes, C., Omer, S., Gilliam, W.
10.1101/2021.07.30.21261383 — Posted: 2021-08-01
KNOWLEDGE AND RISK PERCEPTION OF NIGERIANS TOWARDS THE CORONAVIRUS DISEASE (COVID-19)
Udomah, B. F., Ashaolu, U. O., Olomofe, C. O., Dada, O. F., Soyemi, V. K., Aremu-Kasumu, Y. B., Ochieze, C. J., Adeyemi, O. A., Owolabi, A. O., Igbokwe, M. C., Ajumuka, E. E., Ologunde, K. W., Popoola, G. O., Ariyo, O. E., Fayemi, O. B.
10.1101/2021.07.30.21261351 — Posted: 2021-08-01
Effects of Various Policy Options on COVID-19 Cases in Nova Scotia including Vaccination Rollout Schedule: A Modelling Study
Gillis, M., Saif, A., Murphy, M., Kamal, N.
10.1101/2021.07.28.21261219 — Posted: 2021-07-31
Accuracy verification of low-cost CO2 concentration measuring devices for general use as a countermeasure against COVID-19
Ishigaki, Y., Enoki, K., Yokogawa, S.
10.1101/2021.07.30.21261265 — Posted: 2021-07-31
Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates
Williams, L. R., Ferguson, N. M., Donnelly, C. A., Grassly, N. C.
10.1101/2021.07.30.21260912 — Posted: 2021-07-31
COVID-19 in hospitalized patients in 4 hospitals in San Isidro, Buenos Aires, Argentina
Barra, M. A., Carlos Medinacelli, N. A., Meza Padilla, C. A., Di Rocco, L., Larrea, R. M., Gaudenzi, G., Mastrovincenzo, V. V., Moreno, I., Rana, E., Sorvik, D. A., Sarlingo, A., Dadomo, F., Torrilla, M.
10.1101/2021.07.30.21261220 — Posted: 2021-07-31
Public attitudes towards COVID-19 vaccines in children: A qualitative study
Williams, S. N.
10.1101/2021.07.28.21261252 — Posted: 2021-07-31
Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies
Herrera-Esposito, D., de los Campos, G.
10.1101/2021.07.29.21261282 — Posted: 2021-07-31 Discussion: Offsite
Increased Autotaxin levels in severe COVID-19, correlating with IL-6 levels, endothelial dysfunction biomarkers, and impaired functions of dendritic cells
Nikitopoulou, I., Fanidis, D., Ntatsoulis, K., Moulos, P., Mpekoulis, G., Evangelidou, M., Dimakopoulou, V., Vassiliou, A. G., Jahaj, E., Tsipilis, S., Orfanos, S. E., Dimopoulou, I., Angelakis, E., Akinosoglou, K., Vassilaki, N., Tzouvelekis, A., Kotanidou, A., Aidinis, V.
10.1101/2021.07.30.21261361 — Posted: 2021-07-31
Development of a Post-Acute Sequelae of COVID-19 (PASC) Symptom Lexicon Using Electronic Health Record Clinical Notes
Wang, L., Foer, D., MacPhaul, E., Lo, Y.-C., Bates, D. W., Zhou, L.
10.1101/2021.07.29.21261260 — Posted: 2021-07-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).